Interruption of the PI3K/AKT signaling pathway depletes miR-21 by amplifying PDCD4 and PTEN restoring sensitivity of CML LSCs to TKIs [88]. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.